Pharmafile Logo

News and Press Releases

Nxera Pharma and Shionogi Launch QUVIVIQ™ in Japan for Adults with Insomnia

19 December 2024 – Tokyo, Japan and Cambridge, UK, – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares –...

Category: Drug Delivery, Drug Discovery
Posted: December 19, 2024

SHIONOGI
contact@shionogi.eu
33 Kingsway, London, WC2B 6UF, UK

Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI

5 November 2024 –Tokyo, Japan and London and Cardiff, UK – Nxera Pharma (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – and Antiverse, a techbio...

Category: BioManufacturing
Posted: November 6, 2024

Nxera Pharma
Midtown East 9-7-2 Akasaka Minato-ku Tokyo 107-0052

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024

9 May 2024 -- Tokyo, Japan and Cambridge, UK -- Nxera Pharma provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March...

Category: Drug Discovery, Other
Posted: May 9, 2024

Nxera Pharma
Midtown East 9-7-2 Akasaka Minato-ku Tokyo 107-0052